Enterprise-wide license to Strainprint Analytics, Clinic Edition, will provide unparalleled medical cannabis treatment guidance

TORONTO, Nov 1, 2018 /CNW/ - Strainprint, the leader in cannabis data and analytics, is pleased to welcome GrowWise Health Limited ("GrowWise") to its fast-growing list of subscribing customers. With education centres across Ontario and British Columbia, GrowWise provides comprehensive education and treatment services to help patients and physicians make informed choices about medical cannabis. GrowWise will leverage Strainprint's full technology suite across its network through an enterprise-wide license.

"We are thrilled to be working with GrowWise. Their passion and commitment to helping patients runs deep and that is aligned with everything that we do. Getting the opportunity to roll-out our state-of-the-art platform across the GrowWise network further validates our focus on the scientific understanding of cannabis for medical purposes," said Strainprint CEO, Andrew Muroff.

GrowWise will roll-out the Clinic Edition of the Strainprint Analytics web portal across its clinic network giving patient educators access to more than 38 million data points on strain efficacy from more than 900,000 verified patient interactions – the largest and most granular data set of its kind in the world. This will allow GrowWise to better personalize each patient visit, while at the same time optimize clinic efficiency and throughput.

"GrowWise is committed to helping patients achieve optimal therapeutic benefits from their medication. As we continually look for ways to improve treatment guidance and enhance patient outcomes, we found Strainprint to be the platform that best integrates data gathering functionality with engagement and data visualization tools, along with the most comprehensive and granular source of real-time data," said Breanna Roycroft, Vice President of GrowWise. "The Strainprint platform will complement our existing knowledge base and help us to shape our patient education initiatives now and into the future."

GrowWise patients will access Strainprint's industry-leading patient journaling app through a unique 'activation code'. Patients will be encouraged to log their medication sessions and quickly learn which strains, dosage and administration methods may work best for their symptoms and conditions. By integrating personalized medication history into clinic workflow, GrowWise clinicians can monitor patient performance in real-time [AS2] on Strainprint Analytics and compare patient success against their cohorts in the global data set to optimize treatment guidance and improve quality of life.

The integrated Strainprint platform will also give GrowWise an unparalleled opportunity to conduct any number of retroactive cannabis research studies, for example by specific indication, age, gender or mode of administration.

For more information visit www.strainprintanalytics.com and www.growwisehealth.com.

About Strainprint™

Founded in Toronto in 2016, StrainprintTM Technologies Ltd. is the leading demand-side cannabis data and analytics company. With the world's largest longitudinal, observational data-set of its kind and a mission to advance the scientific understanding of cannabis and its legitimization as a mainstream therapy, Strainprint helps medical cannabis patients and doctors to use cannabis in the most effective and responsible way possible. StrainprintTM data supports global cannabis research and provides advanced business intelligence and treatment guidance to producers, retailers, medical practitioners, pharmacies, government and industry. Strainprint is HIPAA, PIPEDA and PHIPA privacy compliant, military-grade encrypted and all patient data is completely anonymized and at rest in Canada. Strainprint can be seamlessly embedded or integrated with most electronic medical records (EMR) and seed2sale software systems. Strainprint Analytics is accessed by customer subscription. The Strainprint App is free to patients and can be downloaded from both the iOS App Store and GooglePlay Store. www.strainprintanalytics.com. facebook, twitter, linkedin

About GrowWise

GrowWise Health Limited, a subsidiary of Emblem Corp., provides patients and healthcare providers with personalized education to make informed choices about medical cannabis treatments. With education centres across Ontario and British Columbia, prospective patients can learn more at www.growwisehealth.com.

SOURCE Strainprint Technologies Ltd.

For further information: Media Contact: Jessica Moran, 519-494-5379, Strainprint Technologies Ltd., [email protected]